Newlin Investment Company

Overview

Newlin Investment Company is a private equity and venture capital firm that makes long-term investments in selected growth and value opportunities in technology, industrial, and life science markets. The firm is particularly known for its commitment to investing in university spin-outs, emphasizing a collaborative approach to enhance strategic planning, team building, and operational excellence within its portfolio companies. Newlin Investment operates in Pittsburgh, Florida, and Boston. The firm's investment strategy focuses on providing capital for equity in early-stage and growth companies across broad markets, including technology, industrial, and life sciences. Newlin maintains a long-term investing perspective and works as active partners to build growth and business value. Representative investments include Black Dog Ventures, C2Sense, Carmell Therapeutics, Sharp Edge Labs, and SpIntellx. Newlin Investment Company was founded in 2007 and is headquartered in Sewickley, Pennsylvania. The firm's leadership includes Chairman William R. Newlin, who has a background in executive roles and entrepreneurship, and Director William R. Newlin II, who provides assistance concerning operations of certain portfolio companies. The firm emphasizes a collaborative partnership that creates substantial value for its portfolio companies through strategic planning, team building, and financial and operational excellence.

Investment Focus

• Active partnership
• Long-term investment perspective
• Focus on technology, industrial, and life sciences sectors

Portfolio Companies